Alnylam Pharmaceuticals, Inc. (ALNY) Reports $492M Amvuttra Sales, Raises 2025 Revenue Guidance

finance.yahoo.com/news/alnylam-pharmaceuticals-inc-alny-reports-163315818.html

We recently compiled a list of the 12 Best Performing Healthcare Stocks to Buy Right Now. Alnylam Pharmaceuticals, Inc. is one of them.
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), a leading biotech company specializing in RNA interference (RNAi) therapeutics, is advancing treatments for…

This story appeared on finance.yahoo.com, 2025-09-30 16:33:15.
The Entire Business World on a Single Page. Free to Use →